Bafna Pharmaceuticals has informed that the board of directors of thecompany at its meeting held on February 10, 2012 has transacted the appointment of A. Sahasranaman, independent director on the board of subsidiary Bafna Lifestyles Remedies .
The above information is part of company’s filing submitted to the BSE.